Literature DB >> 8297148

The efficacy of phloridzin and phloretin on tumor cell growth.

J A Nelson1, R E Falk.   

Abstract

This study utilized phloridzin (P1) and its aglucone phloretin (P2), two known inhibitors of glucose transmembrane transport, to inhibit tumor cell growth in vivo. The efficacy of hydrazine sulfate as an anticachexic agent was also evaluated. Utilizing the rat mammary adenocarcinoma and Fischer bladder cell carcinoma cell lines, it has been shown that the i.p. administration of P1 and P2 can produce significant differences in mean tumor diameters as compared to the untreated controls.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8297148

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  21 in total

1.  Inhibition of the electrostatic interaction between beta-amyloid peptide and membranes prevents beta-amyloid-induced toxicity.

Authors:  C Hertel; E Terzi; N Hauser; R Jakob-Rotne; J Seelig; J A Kemp
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-19       Impact factor: 11.205

2.  Phloridzin docosahexaenoate, a novel flavonoid derivative, suppresses growth and induces apoptosis in T-cell acute lymphoblastic leukemia cells.

Authors:  Niroshaathevi Arumuggam; Nicole Melong; Catherine Kl Too; Jason N Berman; Hp Vasantha Rupasinghe
Journal:  Am J Cancer Res       Date:  2017-12-01       Impact factor: 6.166

3.  Kava chalcone, flavokawain A, inhibits urothelial tumorigenesis in the UPII-SV40T transgenic mouse model.

Authors:  Zhongbo Liu; Xia Xu; Xuesen Li; Shuman Liu; Anne R Simoneau; Feng He; Xue-Ru Wu; Xiaolin Zi
Journal:  Cancer Prev Res (Phila)       Date:  2013-10-11

4.  Anticancer agents interacting with membrane glucose transporters.

Authors:  C Granchi; S Fortunato; F Minutolo
Journal:  Medchemcomm       Date:  2016-07-08       Impact factor: 3.597

Review 5.  Unconventional therapies for cancer: 4. Hydrazine sulfate. Task Force on Alternative Therapies of the Canadian Breast Cancer Research Initiative.

Authors:  E Kaegi
Journal:  CMAJ       Date:  1998-05-19       Impact factor: 8.262

Review 6.  Apple phenolics as nutraceuticals: assessment, analysis and application.

Authors:  Shalika Rana; Shashi Bhushan
Journal:  J Food Sci Technol       Date:  2015-11-23       Impact factor: 2.701

Review 7.  Anticancer agents that counteract tumor glycolysis.

Authors:  Carlotta Granchi; Filippo Minutolo
Journal:  ChemMedChem       Date:  2012-06-08       Impact factor: 3.466

Review 8.  MRS and MRSI guidance in molecular medicine: targeting and monitoring of choline and glucose metabolism in cancer.

Authors:  Kristine Glunde; Lu Jiang; Siver A Moestue; Ingrid S Gribbestad
Journal:  NMR Biomed       Date:  2011-07       Impact factor: 4.044

Review 9.  Targeting metabolic transformation for cancer therapy.

Authors:  Daniel A Tennant; Raúl V Durán; Eyal Gottlieb
Journal:  Nat Rev Cancer       Date:  2010-03-19       Impact factor: 60.716

10.  Anticancer targets in the glycolytic metabolism of tumors: a comprehensive review.

Authors:  Paolo E Porporato; Suveera Dhup; Rajesh K Dadhich; Tamara Copetti; Pierre Sonveaux
Journal:  Front Pharmacol       Date:  2011-08-25       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.